Picture of Nephros logo

NEPH — Nephros News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapNeutral

Nephros Inc reports results for the quarter ended in December - Earnings Summary

* Nephros Inc  NEPH.OQ  reported a quarterly adjusted loss
of 6
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -10
cents.  The mean expectation of two analysts for the quarter was
for a loss of 2 cents per share. Wall Street expected results to
range from -4 cents to -1 cents per share.
    * Revenue rose 27.2% to $3.25 million from a year ago;
analysts
expected $3.81 million. 
    * Nephros Inc's reported EPS for the quarter was a loss of 6
cents​.
    * The company reported a quarterly loss of $654 thousand.
    * Nephros Inc shares had fallen by 10.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the environmental
services & equipment peer group is  "hold."

Wall Street's median 12-month price target for Nephros Inc is
$4.50 
This summary was machine generated from LSEG data March 8 at
04:25 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.02          -0.06          Missed
 Sep. 30 2023      -0.06          -0.02          Beat
 Jun. 30 2023      -0.05          -0.04          Beat
 Mar. 31 2023      -0.02          -0.03          Missed

Recent news on Nephros

See all news